December 2016
Welcome to the December issue. Upfront investigates the fate of the EMA’s headquarters after Brexit, a ‘number one’ mystery and ultra-long acting drug delivery. Our cover feature, celebrates the most exciting drug development and manufacturing technologies released during 2016. NextGen asks what ISPE’s 2016 Facility of the Year Awards tell us about the future direction of the industry, and in Best Practice, Jasmine explains why multivariate statistical modeling can play a key role in Quality by Design. We also sit down with Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation.
Accessing Big Pharma’s Conscience
December 14, 2016
Sitting Down With... Jayasree K. Iyer, Executive Director, Access to Medicine Foundation, Haarlem, the Netherlands.
1 min read
Time to Dive into Design of Experiments
December 14, 2016
Data, data everywhere... But pharma is not making the most out of it. Multivariate statistical modeling can play a key role in Quality by Design. Here’s how.
1 min read
Riding the Cell Therapy Wave
December 14, 2016
A surge of exciting new cellbased treatments is coming – but is the industry ready to manufacture them and catch the wave to success?
1 min read
Facility Innovation by Design
December 14, 2016
What do ISPE’s 2016 Facility of the Year Awards tell us about the future direction of the industry?
1 min read
Words Of A Winner
December 14, 2016
We catch up with the winner of The Medicine Maker 2015 Innovation Awards, LEO Pharma.
1 min read
Innovation Returns
December 14, 2016
The Medicine Maker Innovation Awards are back for the second year to recognize the most exciting drug development and manufacturing technologies released during 2016.
1 min read
Finding Fakes
December 14, 2016
Looking at the past, present and future of counterfeit drugs screening.
1 min read
Finding a Fumigant
December 14, 2016
Formaldehyde’s days as a fumigant are numbered, but choosing an alternative isn’t easy. Here are some things to consider…
1 min read
Why Share Your Biosimilars Cake?
December 14, 2016
Biosimilar drugmakers should remember that the best cake – and the best biosimilar – is one that you don’t have to share with competitors.
1 min read
Location, Location, Location
December 14, 2016
An EMA task force prepares for the worst should the Agency be forced to leave London post-Brexit
1 min read
Number One Mystery
December 14, 2016
How solving a riddle about pungent camel urine could lead to potential diagnostics or treatments for African sleeping sickness
1 min read
The Power is Close at Hand
December 14, 2016
Nominations are open for the 2017 Power List, but will close in February 2017
1 min read
CAR-T Tragedy
December 14, 2016
More deaths in Juno’s cancer immunotherapy trial raise questions over CAR-T safety, as well as FDA transparency
1 min read
Safe Passage for Cures
December 14, 2016
The 21st Century Cures Act is passed through US Congress – and includes big plans for the FDA
1 min read
Star Treatment
December 14, 2016
Can star-shaped drug delivery capsules be the solution for ultra-long acting delivery?
1 min read
Ending 2016 with Storms and Celebrations
December 13, 2016
A drug pricing tempest is building for 2017, but it shouldn’t overshadow the great and good in the industry.
1 min read
